arch23
EN_01213186_2753
Dr. Michel Sadelain, Director of the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center in New York, who came to think early in his career that gene therapy could be used to alter T-cells to fight cancer, in Washington, May 5, 2016. After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer. (Jesse Dittmar/The New York Times)
MINIMALNA CENA 100USD!!!
2014-05-04
JESSE DITTMAR/The New York Times/EAST NEWS
The New York Times Agency
JESSE DITTMAR
h_14853506
2,46MB
38cm x 30cm by 300dpi
2016, 5, A, AFTER, ALTER, AMERICA, ARE, AT, BE, BRINGING, CAME, CANCER, CAREER, CELL, CENTER, CLOSE, COULD, DARING, DIRECTOR, DITTMAR, DR, EARLY, ENGINEERING, FIGHT, FOR, GENE, HIS, IMMUNE, IN, INTENSE, JESSE, KETTERING, LONG, MARKET, MAY, MEMORIAL, MICHEL, NEW, NORTH, OF, PATIENTS, PORTRAIT, PURSUIT, RESEARCHERS, SADELAIN, SLOAN, SURGEON, SYSTEM, T-CELLS, THAT, THE, THERAPY, THINK, TIMES, TO, TREATMENT, TUMER, TURBOCHARGES, USED, WASHINGTON, WHO, YORK,